Congratulations to Nicholas Jacobson, CTBH Deputy Director of the Treatment Development & Evaluation Core, on his recent award from the Dartmouth Cancer Center! The innovative project, Precision Prevention of Cancer at Scale: Using Digital Phenotyping to Monitor and Target Modifiable Mental Health Risk Factors via a Smartphone App is part of the Dartmouth Cancer Center’s new Precision Prevention initiative and will evaluate the efficacy of a personalized digital intervention targeting anxiety and depressive symptoms in reducing cancer risk. Specifically, the study will use passively collected data from smartphones to examine whether the intervention may work to reduce cancer risk by reducing sleep disturbances and by increasing energy expenditure, social contact, exposure to natural light, and/or heart rate flexibility.
More information about this exciting new project can be found here.